Jaguar Health (JAGX) Preferred Stock Liabilities (2014 - 2026)

Jaguar Health (JAGX) has 9 years of Preferred Stock Liabilities data on file, last reported at $9.5 million in Q1 2026.

• Preferred Stock Liabilities for Q1 2026 came in at $9.5 million, up 281.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.5 million (up 281.09% YoY), and the FY2025 annual result was $2.5 million, changed 0.0% from the prior year.
• Preferred Stock Liabilities grew to $9.5 million in Q1 2026 per JAGX's latest filing, from $2.5 million in the prior quarter.
• Over five years, Preferred Stock Liabilities peaked at $9.5 million in Q1 2026 and troughed at $2.5 million in Q1 2024.
• A 3-year average of $3.5 million and a median of $2.5 million in 2024 frame the typical range for Preferred Stock Liabilities.
• The sharpest annual moves came in 2025 and 2026: Preferred Stock Liabilities changed 0.0% in 2025, then jumped 281.09% in 2026.
• A 3-year view of Preferred Stock Liabilities shows it stood at $2.5 million in 2024, then changed by 0.0% to $2.5 million in 2025, then jumped by 281.09% to $9.5 million in 2026.
• Business Quant data shows JAGX's Preferred Stock Liabilities at $9.5 million in Q1 2026, $2.5 million in Q4 2025, and $2.5 million in Q1 2025.